Nutritional and Metabolic Diseases: News and Research on Osteoporosis

MeSH tree: C18.452.104.579

Nucleic acid drug iSN40 shows promise for osteoporosis treatment

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has highlighted the role of osteogenic CpG oligodeoxynucleotide (iSN40) in promoting osteoblast differentiation ...

Common thyroid medicine linked to bone loss

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone loss, according to a study being presented at the annual meeting of the Radiological Society of North ...

page 14 from 34